Evidence map›Paper›PMID 41573968›Full record

ArticlebioRxiv : the preprint server for biology2026

Cryo-EM Structures of Apo, Agonist- and Antagonist-Bound Heteromeric Kainate Receptors.

Changping Zhou, Guadalupe Segura-Covarrubias, Ashlee M'Kay Hoffman, Nami Tajima

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Guadalupe Segura-CovarrubiasORCID 0000-0002-0979-181X
Ashlee M'Kay HoffmanORCID 0009-0009-7776-1733

Funding

Structure and Function of native kainate-type ionotropic glutamate receptor complexesR35GM147266 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI NAMI TAJIMA · 2022 to 2026
$2.1M
Acquisition of 200kV Glacios Cryo Transmission Electron MicroscopeS10OD032437 · OD · CASE WESTERN RESERVE UNIVERSITY · PI CHAKRAPANI, SUDHA · 2022 to 2022
$2.0M
NIGMS NIH HHS R35 GM147266NIH HHS S10 OD032437
6 · The paper itself

Abstract

Kainate receptors (KARs) mediate excitatory synaptic transmission and regulate neurotransmitter release. In the central nervous system, KARs predominantly exist as heterotetramers comprising low-affinity (GluK1-3) and high-affinity (GluK4-5) subunits, with GluK2/GluK5 being the most abundant. To elucidate their conformational transitions, we determined the cryo-electron microscopy (cryo-EM) structures of GluK2/GluK5 KARs in the apo and distinct ligand-bound states. The apo structure revealed compact packing with extensive inter-subunit interactions between the ligand-binding domains (LBDs) beyond the conserved D1-D1 upper-lobe contacts. The glutamate-bound structure exhibited enhanced packing that stabilized the desensitized conformation through increased intersubunit contacts relative to the homomeric KARs, indicating that the heterotetramers were conformationally less dynamic. To investigate subtype-specific antagonism, we engineered GluK2 and GluK5 mutants with altered affinities for the competitive antagonist UBP310. Structural analysis of these mutants revealed distinct UBP310 binding modes on the GluK2 versus the GluK5 subunits. Furthermore, we demonstrated that targeting GluK5 was more effective than targeting GluK2. Specifically, blocking GluK5 locked the receptor in a pore-occluded conformation, whereas antagonizing GluK2 retained structural flexibility above the pore. These findings provide a structural framework for understanding the distinct contributions of the GluK2 and GluK5 subunits to KAR function. Teaser: Cryo-EM structures of heteromeric kainate receptors reveal unique assembly and regulation mechanisms.

Identifiers

PMID41573968
PMCPMC12822752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.